Jiao Y - Search Results

1

High FHL2 mRNA expression and its prognostic value in lung cancer.

Jiao Y, Wei J, Li Z, Zhou J, Liu Y. Jiao Y, et al. Aging (Albany NY). 2022 Oct 10;14(19):7986-8000. doi: 10.18632/aging.204328. Epub 2022 Oct 10. Aging (Albany NY). 2022. PMID: 36227138 Free PMC article.

2

High EIF2B5 mRNA expression and its prognostic significance in liver cancer: a study based on the TCGA and GEO database.

Jiao Y, Fu Z, Li Y, Meng L, Liu Y. Jiao Y, et al. Cancer Manag Res. 2018 Nov 20;10:6003-6014. doi: 10.2147/CMAR.S185459. eCollection 2018. Cancer Manag Res. 2018. PMID: 30538549 Free PMC article.

3

Aberrant FAM64A mRNA expression is an independent predictor of poor survival in pancreatic cancer.

Jiao Y, Fu Z, Li Y, Zhang W, Liu Y. Jiao Y, et al. PLoS One. 2019 Jan 29;14(1):e0211291. doi: 10.1371/journal.pone.0211291. eCollection 2019. PLoS One. 2019. PMID: 30695070 Free PMC article.

4

Low CYP24A1 mRNA expression and its role in prognosis of breast cancer.

Cai H, Jiao Y, Li Y, Yang Z, He M, Liu Y. Cai H, et al. Among authors: jiao y. Sci Rep. 2019 Sep 23;9(1):13714. doi: 10.1038/s41598-019-50214-z. Sci Rep. 2019. PMID: 31548577 Free PMC article.

5

A new prognostic factor of breast cancer: High carboxyl ester lipase expression related to poor survival.

Cui Y, Jiao Y, Wang K, He M, Yang Z. Cui Y, et al. Among authors: jiao y. Cancer Genet. 2019 Nov;239:54-61. doi: 10.1016/j.cancergen.2019.09.005. Epub 2019 Sep 18. Cancer Genet. 2019. PMID: 31561066 Free article.

6

High peroxidasin-like expression is a potential and independent prognostic biomarker in breast cancer.

Li Y, Jiao Y, Luo Z, Li Y, Liu Y. Li Y, et al. Among authors: jiao y. Medicine (Baltimore). 2019 Nov;98(44):e17703. doi: 10.1097/MD.0000000000017703. Medicine (Baltimore). 2019. PMID: 31689799 Free PMC article.

7

Expression of La Ribonucleoprotein Domain Family Member 4B (LARP4B) in Liver Cancer and Their Clinical and Prognostic Significance.

Li Y, Jiao Y, Li Y, Liu Y. Li Y, et al. Among authors: jiao y. Dis Markers. 2019 Oct 22;2019:1569049. doi: 10.1155/2019/1569049. eCollection 2019. Dis Markers. 2019. PMID: 31772683 Free PMC article.

8

OGDHL Expression as a Prognostic Biomarker for Liver Cancer Patients.

Jiao Y, Li Y, Fu Z, Hou L, Chen Q, Cai Y, Jiang P, He M, Yang Z. Jiao Y, et al. Dis Markers. 2019 Oct 17;2019:9037131. doi: 10.1155/2019/9037131. eCollection 2019. Dis Markers. 2019. PMID: 31781311 Free PMC article.

9

Elevated high mobility group A2 expression in liver cancer predicts poor patient survival.

Zhao YC, Jiao Y, Li YQ, Fu Z, Yang ZY, He M. Zhao YC, et al. Among authors: jiao y. Rev Esp Enferm Dig. 2020 Jan;112(1):27-33. doi: 10.17235/reed.2019.6365/2019. Rev Esp Enferm Dig. 2020. PMID: 31823639 Free article.

10

Clinical Value of lncRNA LUCAT1 Expression in Liver Cancer and its Potential Pathways.

Jiao Y, Li Y, Ji B, Cai H, Liu Y. Jiao Y, et al. J Gastrointestin Liver Dis. 2019 Dec 9;28(4):439-447. doi: 10.15403/jgld-356. J Gastrointestin Liver Dis. 2019. PMID: 31826070 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,371 results

Search Page

Filters